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        Schwann cells develop in contact with and dependent on axons 
for signals that promote their genesis and subsequent differen-
tiation (  Jessen and Mirsky, 2005  ). In mature nerves, Schwann 
cells adopt one of two distinct fates: a nonmyelinating pheno-
type, in which multiple small-diameter axons are separately en-
closed within pockets of the Schwann cell (forming a Remak 
bundle), or a myelinating phenotype, in which they acquire a 
one/one association with and subsequently myelinate larger 
axons that express the promyelinating signal neuregulin 1 (  Fig. 1  ; 
  Nave and Salzer, 2006  ). Myelinating Schwann cells remain 
remarkably plastic throughout life. Thus, during Wallerian 
degeneration, axon transection initiates rapid Schwann cell de-
differentiation (i.e., down-regulation of myelin protein expression 
and up-regulation of nonmyelin markers) and proliferation 
(  Scherer and Salzer, 2001  ). These reprogrammed cordons of 
Schwann  cells,  termed   “ bands  of  B ü ngner, ”   provide  a  cellular 
substrate for nerve regeneration and subsequent remyelination. 
The events that underlie these changes in Schwann cell differen-
tiation have been largely obscure. In the current issue, Parkinson 
et al. (see p. 625) provide important insights into the mecha-
nisms by which injury promotes Schwann cell dedifferentiation. 
They show that the transcription factor c-Jun is up-regulated 
upon injury and antagonizes Krox-20, an important promyelin-
ating transcription factor, to promote a switch in the Schwann 
cell phenotype. 
Schwann cells are remarkably plastic cells that can both 
form and stably maintain myelin sheaths around axons 
and also rapidly dedifferentiate upon injury. New ﬁ  nd-
ings (Parkinson, D.B., A. Bhaskaran, P. Arthur-Farraj, L.A. 
Noon, A. Woodhoo, A.C. Lloyd, M.L. Feltri, L. Wrabetz, 
A. Behrens, R. Mirsky, and K.R. Jessen. 2008.   J. Cell Biol  . 
181:625  –  637) indicate that the transition between these 
distinct states of differentiation is directed by the transcrip-
tion factor Krox-20, which promotes and maintains mye-
lination, and c-Jun, which antagonizes it. Cross-inhibition 
of these transcription factors serves to switch Schwann 
cells between the myelinated and dedifferentiated pheno-
types, respectively.
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  Previous work on the regulation of the Schwann cell lin-
eage focused on elucidating the transcriptional cascade that pro-
motes myelination (  Jessen and Mirsky, 2005  ). Among these are 
factors that promote glial/Schwann cell specifi  cation and initial 
differentiation (e.g., Sox10 and NF    B) and those that promote 
Schwann cell differentiation to the promyelinating stage (i.e., 
Oct-6/SCIP and Brn2;   Fig. 1  ). The latter transcription factors, 
together with Sox10 (  Ghislain and Charnay, 2006  ), are required 
for the expression of Krox-20 (Egr2), which is essential for 
Schwann cell myelination. Recently, conditional inactivation of 
Krox-20 in the adult was shown to result in demyelination, in-
dicating that Krox-20 is also required to maintain the myelin 
sheath long after it has formed (  Decker et al., 2006  ). 
    Parkinson et al. (2008)   have now examined the role of c-Jun, 
a basic leucine zipper transcription factor and an important 
component of the AP-1 complex, in Schwann cell myelination. 
In previous studies, they reported that c-Jun is expressed by and 
promotes Schwann cell proliferation before myelination and that 
c-Jun  ’  s expression is then down-regulated at the onset of mye-
lination by Krox-20 (  Parkinson et al., 2004  ). In the current study, 
they demonstrate that c-Jun can potently inhibit myelination. 
Thus, forced expression of c-Jun inhibits myelin gene expression 
in cultured Schwann cells in response to promyelinating factors 
and also blocks myelination in neuron  –  Schwann cell cocultures. 
Loss of c-Jun by conditional inactivation of a fl  oxed allele 
enhanced myelin gene expression in cultured Schwann cells. 
These results suggest that c-Jun expression may regulate the 
onset of myelination during development, although its precise 
role during development remains to be determined. 
  It is of note that c-Jun is rapidly up-regulated in Schwann 
cells after injury. Explanting Schwann cells from nerves into 
culture (which removes them from contact with axons), treating 
myelinating cocultures with high doses of a growth factor to 
induce demyelination, or transecting nerves to initiate Wallerian 
degeneration all up-regulate c-Jun expression. This up-regulation 
appears to play an important role in promoting dedifferentiation. 
Conditional inactivation of c-Jun markedly delayed Schwann 
cell dedifferentiation under the aforementioned conditions, 
including, strikingly, during Wallerian degeneration of neonatal 
nerves. In the latter case, myelin sheaths remained intact even 
several days after axon transection. These fi  ndings indicate c-Jun 
activation has an important involvement in promoting dediffer-
entiation of Schwann cells after injury. Although dedifferentia-
tion and myelin sheath breakdown were signifi  cantly delayed, 
they still occurred, suggesting that other pathways may be involved 
(see subsequent paragraphs). 
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Each of these kinase pathways has been implicated in regulating 
Schwann cell differentiation. The Ras  –  MAPK pathway, like the 
JNK pathway, is a negative regulator of Schwann cell differ-
entiation and myelination (  Harrisingh et al., 2004  ;   Ogata et al., 
2004  ). In contrast, p38 kinase (  Haines et al., 2008  ), as well as 
phosphatidylinositol 3-kinase (  Maurel and Salzer, 2000  ), is pro-
myelinating. These fi  ndings suggest that a dynamic balance be-
tween promyelination and dedifferentiation signaling pathways 
operates during development and injury. This balance between pro-
myelination and dedifferentiation may be refl  ected in the dynamic 
switch between Krox-20 versus c-Jun and Sox-2, respectively. 
  Finally, these studies have important implications for the 
adaptive changes in Schwann cell differentiation that occur during 
development and after injury but likely in pathological settings 
as well. Many demyelinating neuropathies are characterized by 
Schwann cell dedifferentiation and proliferation (  Feldman et al., 
2008  ), and an emerging literature suggests that aberrant MAPK 
signaling may be involved (  Cavaletti et al., 2007  ). As such, these 
pathways, including the JNK signaling pathway highlighted by 
the studies of   Parkinson et al. (2008)  , may be attractive candi-
dates for targeted therapeutic intervention. 
Submitted:   23 April 2008 
Accepted:   25 April 2008 
  References 
   Cavaletti ,   G. ,   M.    Miloso ,   G.    Nicolini ,  A.    Scuteri ,  and   G.   Tredici .   2007 .   Emerging 
role of mitogen-activated protein kinases in peripheral neuropathies.   
  J. Peripher. Nerv. Syst.     12 : 175  –  194 .    
   Decker ,   L. ,   C.    Desmarquet-Trin-Dinh ,   E.    Taillebourg ,   J.    Ghislain ,   J.M.    Vallat , 
and   P.    Charnay .   2006  .   Peripheral myelin maintenance is a dynamic pro-
cess requiring constant Krox20 expression.       J. Neurosci.     26 : 9771  –  9779 .    
   Feldman ,   E.L. ,   D.R.    Cornblath ,   J.    Porter ,   R.    Dworkin ,  and   S.    Scherer .   2008 . 
  National Institute of Neurological Disorders and Stroke (NINDS): 
advances in understanding and treating neuropathy, 24-25 October 2006; 
Bethesda, Maryland.       J. Peripher. Nerv. Syst.     13 : 1  –  6 .    
  How does c-Jun promote dedifferentiation?   Parkinson 
et al. (2008)   provide strong evidence that c-Jun functions by 
antagonizing the expression of Krox-20. Forced expression of 
c-Jun suppresses Krox-20, but not Oct-6, induction. Conversely, 
inactivation of c-Jun delays the down-regulation of Krox-20 that 
normally occurs after injury. As loss of Krox-20 by itself leads to 
myelin breakdown (  Decker et al., 2006  ), these fi  ndings suggest 
that the induction of c-Jun during injury triggers myelin breakdown 
by inhibiting Krox-20. Interestingly, c-Jun may act synergistically 
with another transcription factor, Sox-2, which was previously 
shown to also inhibit myelination (  Le et al., 2005  ). Expression of 
c-Jun and Sox-2 appear to be coregulated. Both are expressed 
early in the Schwann cell lineage, down-regulated with myelin-
ation, and rapidly reexpressed upon injury, which suggests that 
they may cooperate in their dedifferentiative effects. 
  c-Jun is a downstream target of JNK, a serine-threonine 
kinase that directly phosphorylates c-Jun, enhancing its activity 
and expression (  Johnson and Nakamura, 2007  ). JNK is phos-
phorylated and activated by MAPK kinases (MKK), including 
MKK7.   Parkinson et al. (2008)   detected robust phospho  –  c-Jun 
expression shortly after nerve injury, which implicates the JNK 
pathway in Schwann cell dedifferentiation after injury. In agree-
ment with this, forced expression of MKK7 in Schwann cells 
phenocopied the inhibitory effects of c-Jun on myelination. 
Whether this rapid increase in c-Jun expression and JNK activ-
ity refl  ects the loss of promyelinating signals provided by the 
axon, the expression of injury signals from the transected nerve 
(  Scherer and Salzer, 2001  ), or both is not yet known. Interest-
ingly, c-Jun also inhibits myelin gene expression independently 
of the N-terminal phosphorylation classically mediated by JNK, 
which suggests that the main involvement of JNK may be to 
control c-Jun levels. 
  The JNK pathway is one of the three canonical MAPK sig-
naling pathways, which also include the MAPK and p38 kinases. 
  Figure 1.       Regulation of Schwann cell mye-
lination and dedifferentiation.   (A) Schwann cell 
differentiation is regulated by expression of 
speciﬁ  c transcription factors. Immature Schwann 
cells receive axonal signals, including neu-
regulin 1 (NRG), which up-regulate expression 
of transcription factors including NF    B, Oct-6, 
and Brn2. These transcription factors promote 
the promyelinating stage, in which Schwann 
cells acquire a one/one association with the 
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